K 7259
Latest Information Update: 04 Sep 2002
Price :
$50 *
At a glance
- Originator Kowa
- Developer Kowa; Nonindustrial source
- Class Anti-ischaemics; Neuroprotectants; Nootropics
- Mechanism of Action Free radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cognition disorders; Ischaemic heart disorders; Neurological disorders